ShiraTronics

07/16/2025

This week, ShiraTronics, Inc. is proud to join leading innovators and clinicians at the 2025 American Society of Pain and Neuroscience ASPN Meeting in Miami - a gathering dedicated to the future of pain management and neuromodulation.

We're here to share progress, spark dialogue, and advance the conversation around drug-free, implantable neurotechnology for chronic migraine, a condition that affects millions and demands better solutions.

📣 Be sure to catch our CEO, Rob Binney, who will be contributing to two engaging panels this Thursday (7/17):
▶️ “Running a Start-up Company – Challenges and Tips” | 9:30 AM – 10:00 AM ET
▶️ “Industry Mergers and Acquisitions: How to Position Your Business for Acquisition and What Businesses to Acquire” | 10:30 AM – 11:00 AM ET

Rob brings a unique perspective shaped by leadership roles across multiple medical specialties, from start-up growth to strategic M&A - offering insights on scaling innovation in complex healthcare markets.

📍 Connect with us to learn more about our ongoing RELIEV-CM2 pivotal study and our mission to bring new hope to patients who live with daily migraine.

Let’s reimagine what relief can look like.

07/11/2025

Migraine Is Rising - And So Must We

A recent global study published by the National Library of Medicine reveals the staggering growth of migraine worldwide.

The numbers speak volumes:
▶️ From 732 million in 1990 to 1.16 billion people living with migraine by 2021
▶️ Migraine-related disability-adjusted life years (DALYs) have surged in parallel
▶️ Projections show continued growth through 2050, across age groups and geographies

This isn’t just a neurological condition, it’s one of the fastest-growing, under-recognized burdens in global health.

At ShiraTronics, Inc., we see these trends as a call to action. Our mission is to develop and evaluate innovative implantable neuromodulation therapies that may one day help reduce the impact of chronic migraine for those who have exhausted conventional options.

We’re here to move the science forward because behind every data point is a life waiting for relief.

Caution: Investigational device. Limited by Federal (or United States) law to investigational use.

07/04/2025

Happy 4th of July from ShiraTronics!

Today we celebrate independence, resilience, and the drive to create a better future for those living with chronic migraine. As we honor this day of freedom, we’re reminded of our own mission: to empower patients through innovation, research, and compassion.

Wishing you a safe and meaningful holiday.

06/20/2025

🌍 We’re honored to be recognized in BioSpectrum Asia’s “MedTech Disruption 2025: Startups Powering the Next Healthcare Leap” as a top startup to watch in advanced neuromodulation.

🔬 As we advance pivotal trials for our investigational, drug-free Migraine Therapy System, this acknowledgment highlights the urgent need for innovative solutions for people living with chronic migraine.

🎯 At ShiraTronics, our focus is clear: bring forward new science, restore quality of life, and offer hope where conventional therapies have fallen short.

https://www.biospectrumasia.com/opinion/27/26130/medtech-disruption-2025-startups-powering-the-next-healthcare-leap.html

Caution: Investigational device. Limited by Federal (or United States) law to investigational use.

06/16/2025

We’re looking forward to joining leading clinicians and researchers next week at the American Headache Society (AHS) Annual Scientific Meeting in Minneapolis. As part of a shared effort to improve care for chronic migraine, we're looking forward to meaningful discussions around emerging clinical evidence and evolving treatment strategies.

🧠 Our team is committed to advancing new approaches for patients living with chronic migraine — including the ongoing investigation of a fully implantable, head-based neuromodulation system designed to target key nerve pathways involved in migraine.

📍 If you’re attending AHS, we’d welcome the opportunity to connect. Whether you're engaged in research, patient care, or innovation, let’s find time to talk while we’re in Minneapolis!

Caution: Investigational device. Limited by Federal (or United States) law to investigational use.

05/29/2025

🧠 Chronic migraine doesn’t just disrupt health - it quietly reshapes careers, relationships, and futures.

Recent research highlights the hidden toll migraines take in the workplace:
▶️ Presenteeism - working while impaired by migraine - accounts for a staggering 39% loss in productivity.
▶️ Absenteeism - days entirely lost to migraine - adds another 1.9% in lost productivity.

The numbers tell a powerful story: chronic migraine doesn’t just keep people home - it forces them to push through debilitating symptoms, often at great personal cost.

At ShiraTronics, we believe chronic migraine demands better answers.
Through dedicated research and collaboration with leading clinicians, we are working to advance innovative therapies that could offer new hope to those living with this debilitating condition. Every study, every milestone, brings us closer to delivering meaningful relief where it’s needed most.

As we enter into Migraine Awareness Month, we honor the strength of those living with migraine every day - and we renew our commitment to advancing science that moves life forward.

🌟 Learn more about how we’re working to help reimagine the future of migraine care.
https://shiratronics.com/

Caution: Investigational device. Limited by Federal (or United States) law to investigational use.

05/22/2025

For millions living with chronic migraine, life doesn’t just "slow down" - it can feel like it disappears.

Days blur into darkness. Plans get canceled. Careers, relationships, and dreams are put on hold.

At ShiraTronics, we refuse to accept that reality.

Our ShiraTronics Migraine Therapy System - an investigational, drug-free, implantable device - is being studied to assess its potential to reduce the frequency and burden of chronic migraine. Specifically engineered to be a head-located device, the system is intentionally designed to deliver targeted neuromodulation directly to the nerve pathways associated with migraine.

Our mission is bold, but clear:
▶️ Fewer headache days.
▶️ Less disruption.
▶️ More life, more possibility.

Because behind every migraine is a person - a mother, a father, a friend, a colleague - who deserves the chance to reclaim the life that migraine interrupts.

🌟 Join us as we advance scientific research, working to deliver meaningful hope for those living with the daily challenges of chronic migraine.

Caution: Investigational device. Limited by Federal (or United States) law to investigational use.

05/15/2025

For Millions of Women, Migraine Means Missing Out. It’s Time for Change.

During National Women’s Health Week, we honor the strength of women living with migraine - a serious neurological disorder that impacts far more than just physical health.

• 70% of chronic migraine sufferers are women.

• Migraine often strikes during critical phases of life - affecting careers, families, and personal goals across adulthood.

• Many women endure 15 or more headache days each month, with few long-term solutions available.

At ShiraTronics, we believe women deserve more than temporary relief - they deserve a path forward.

We are pioneering an investigational therapy designed to deliver targeted, gentle stimulation to nerve pathways associated with migraine. Our goal is simple yet powerful: to reduce headache days, restore quality of life, and offer hope where traditional therapies fall short.

This National Women’s Health Week, we recommit to our mission:
👉 To transform the lives of women living with chronic migraine.

Learn more about National Women's Health Week:
🔗 https://womenshealth.gov/nwhw

Discover how ShiraTronics is advancing migraine care:
🔗 Visit us at shiratronics.com

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use.

05/08/2025

We’re thrilled to share that ShiraTronics has been named one of the 10 Best Tech Startups in Minnesota by The Tech Tribune!

At ShiraTronics, we are pioneering a new frontier in the treatment of chronic migraine with our investigational implantable neuromodulation system — a targeted, drug-free therapy designed to reduce headache days and improve quality of life for patients living with chronic migraine.

This recognition reflects the dedication of our team, clinical collaborators, and physician partners who are working tirelessly to bring forward a new solution for one of the most disabling and costly neurological disorders in the U.S. We’re grateful to The Tech Tribune for this recognition and proud to be part of Minnesota’s thriving MedTech community.

Learn more about our mission and technology
� https://ow.ly/xT8G50VO7jr

� Read more about the award: https://ow.ly/OCAy50VO7jt

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use.

05/01/2025

Did you know that common workplace elements like bright lights, loud noises, strong odors, and even stress can trigger migraines?

Identifying and managing these triggers is crucial for reducing migraine frequency and enhancing productivity.

Want to create a more migraine-friendly work environment? Check out this helpful article below for practical tips on making your workspace more comfortable and migraine-friendly: https://www.self.com/story/migraine-triggers-at-work

Let's make health and well-being a priority at work!

Microwaved fish and fluorescent lighting are painful to be around—for lots of reasons.

04/30/2025

What an incredible way to close out in Boston!

We were honored to see our RELIEV-CM clinical study data presented by Dr. Steven Falowski to a standing room only audience. It’s a powerful reflection of the growing momentum behind innovative solutions for chronic migraine — and a testament to the dedication of our entire ShiraTronics team and clinical collaborators.

A huge thank you to everyone who attended the session, engaged with the data, and shared in the excitement around advancing neuromodulation as a new frontier for migraine care.

The future is bright — and we’re just getting started!

04/25/2025

Chronic Migraine (CM) is more than just headaches—it’s life-altering.

This heartfelt story from Jefferson Health highlights the invisible struggles many patients face daily, from navigating stigma to balancing pain management with everyday responsibilities.

Check out Sarah’s story here: https://ow.ly/OMog50Vyht4

At ShiraTronics, we’re driven to create neuromodulation solutions that address these challenges. Together, we can raise awareness and foster empathy for the millions living with CM. Thank you for following our journey.

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use.

Yes, the chronic migraine attacks are daily and part of Sarah Ogden’s life. The diagnosis and pain crippled her before she found strength through lifestyle adoptions to regain control of her own health.